[1] Important: Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
By leading conversations around mindful eating, nutrient optimisation and the intersection of food and pharmaceuticals, you can create meaningful connections with GLP-1 users
Hair loss has been reported by some users of GLP-1 class medications, including retatrutide
Liraglutide, an additional long-acting GLP-1 analog, is used as a therapy for both obesity and diabetes
These effects were completely inhibited by pasireotide
doi: 10.3389/fnut.2026.1794882 Received 23 January 2026 Revised 02 March 2026 Accepted 02 March 2026 Published 24 March 2026 Volume 13 - 2026 Edited by Amin Gasmi, Francophone Society of Nutritherapy and Applied Nutrigenetics, France Reviewed by Meryem Saban Gler, Batman University, Trkiye Updates Copyright 2026 Cengiz Kaynakc